Pinnacle Associates LTD Fibrogen Inc Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$0.79 - $2.83 $4,815 - $17,248	-6,095 Reduced 4.08%	143,204 $123,000
Q2 2023 Jul 26, 2023	SELL	$2.49 - $20.59 $9,549 - $78,962	-3,835 Reduced 2.5%	149,299 $403,000
Q1 2023 May 04, 2023	SELL	$15.95 - $25.18 $25,440 - $40,162	-1,595 Reduced 1.03%	153,134 $2.86 Million
Q4 2022 Jan 31, 2023	SELL	$13.27 - $17.73 $7,962 - $10,638	-600 Reduced 0.39%	154,729 $2.48 Million
Q4 2022 Jan 25, 2023	SELL	$13.27 - $17.73 $45,051 - $60,193	-3,395 Reduced 2.14%	155,329 $0
Q3 2022 Oct 31, 2022	SELL	$11.4 - $14.6 $90,162 - $115,471	-7,909 Reduced 4.75%	158,724 $2.07 Million
Q2 2022 Aug 02, 2022	SELL	$7.94 - $12.96 $152,876 - $249,531	-19,254 Reduced 10.36%	166,633 $1.76 Million
Q1 2022 May 05, 2022	SELL	$12.02 - $16.79 $76,026 - $106,196	-6,325 Reduced 3.29%	185,887 $2.23 Million
Q4 2021 Feb 02, 2022	SELL	$9.93 - $15.39 $239,739 - $371,560	-24,143 Reduced 11.16%	192,212 $2.71 Million
Q3 2021 Oct 19, 2021	SELL	$10.18 - $26.64 $89,075 - $233,100	-8,750 Reduced 3.89%	216,355 $2.21 Million
Q2 2021 Aug 02, 2021	SELL	$18.57 - $35.68 $60,835 - $116,887	-3,276 Reduced 1.43%	225,105 $6 Million
Q1 2021 May 12, 2021	SELL	$31.0 - $55.72 $615,815 - $1.11 Million	-19,865 Reduced 8.0%	228,381 $7.93 Million
Q4 2020 Jan 26, 2021	SELL	$37.09 - $48.97 $499,453 - $659,430	-13,466 Reduced 5.15%	248,246 $9.21 Million
Q3 2020 Oct 23, 2020	SELL	$40.47 - $45.5 $372,971 - $419,328	-9,216 Reduced 3.4%	261,712 $10.8 Million
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $8.86 Million - $11.7 Million	-272,129 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $895,465 - $1.77 Million	-38,432 Reduced 12.38%	272,129 $9.46 Million
Q4 2019 Feb 03, 2020	SELL	$34.58 - $48.06 $758,858 - $1.05 Million	-21,945 Reduced 6.6%	310,561 $13.3 Million
Q3 2019 Nov 08, 2019	SELL	$36.98 - $48.45 $476,302 - $624,036	-12,880 Reduced 3.73%	332,506 $12.3 Million
Q2 2019 Aug 05, 2019	SELL	$35.13 - $55.53 $1.01 Million - $1.6 Million	-28,835 Reduced 7.71%	345,386 $15.6 Million
Q1 2019 May 10, 2019	SELL	$42.83 - $59.91 $274,326 - $383,723	-6,405 Reduced 1.68%	374,221 $20.3 Million
Q4 2018 Feb 05, 2019	SELL	$37.97 - $60.16 $629,200 - $996,911	-16,571 Reduced 4.17%	380,626 $17.6 Million
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $3.37 Million - $4.02 Million	-59,781 Reduced 13.08%	397,197 $24.1 Million
Q2 2018 Aug 08, 2018	SELL	$44.9 - $64.95 $3.48 Million - $5.03 Million	-77,455 Reduced 14.49%	456,978 $28.6 Million
Q1 2018 May 11, 2018	SELL	$45.35 - $61.65 $1.08 Million - $1.47 Million	-23,790 Reduced 4.26%	534,433 $24.7 Million
Q4 2017 Feb 12, 2018	SELL	$41.95 - $60.1 $2.09 Million - $2.99 Million	-49,720 Reduced 8.18%	558,223 $26.5 Million
Q3 2017 Nov 13, 2017	SELL	$33.4 - $53.9 $576,818 - $930,853	-17,270 Reduced 2.76%	607,943 $32.7 Million
Q2 2017 Aug 09, 2017	BUY	N/A	625,213	625,213 $20.2 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account